Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analyst Ratings

Ameriprise Financial: Decrease in Holding Raises Concerns, but Strong Earnings Performance Provides Hope for Future Success

Roberto by Roberto
July 8, 2023
in Analyst Ratings
0
ANGL stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Ameriprise Financial, Inc. (NYSE:AMP) recently experienced a decrease in its position due to a 5.1% reduction in holding by Forsta AP Fonden during the first quarter of this year, as indicated in their Form 13F filing with the Securities and Exchange Commission. This move resulted in the sale of 2,100 shares, leaving the fund with a total of 38,700 shares of Ameriprise Financial’s stock. At the end of the reporting period, Forsta AP Fonden’s holdings were valued at $11,862,000.

The most recent quarterly earnings data from Ameriprise Financial was released on April 25th. The company reported earnings per share (EPS) of $7.25 for the quarter, surpassing the consensus estimate by $0.04. Additionally, Ameriprise Financial generated revenue of $3.74 billion during this period, outperforming the consensus estimate of $3.69 billion.

Notably, Ameriprise Financial demonstrated a net margin of 15.41% and a return on equity of 77.32%. In comparison to the same quarter last year, its revenue increased by 3.2%. During that prior year’s corresponding quarter, the company earned an EPS of $5.98.

Analysts anticipate that Ameriprise Financial will achieve earnings per share of $30.05 for the current fiscal year—a promising projection moving forward.

Ameriprise Financial operates through four key segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions and Corporate & Other’. Through these divisions and its various subsidiaries, it offers an array of financial products and services to individual and institutional clients across both domestic and international markets.

The Advice & Wealth Management segment focuses on providing personalized financial advice and tailored investment solutions to meet clients’ diverse needs effectively. This includes comprehensive planning services related to retirement preparation and wealth accumulation.

The Asset Management segment concentrates on managing a broad range of investment products for retail and institutional clients. This includes equity, fixed income, and cash management strategies to achieve the clients’ specific investment objectives.

Meanwhile, the Retirement & Protection Solutions segment primarily offers annuities and insurance products designed to provide retirement income and protect against unforeseen events or risks.

Lastly, the Corporate & Other segment encompasses various departmental expenses not allocated to the other segments.

As one of the leading financial services providers in its field, Ameriprise Financial continues to be a prominent player in both domestic and international markets. With its diversified product offerings across multiple market segments, the company is well-positioned to meet the evolving needs of individual and institutional clients alike.

The recent decrease in holding by Forsta AP Fonden may raise questions about Ameriprise Financial’s future performance and investor sentiment. However, with its impressive quarterly earnings results exceeding expectations, it remains hopeful that this setback is merely a temporary contraction within a larger trajectory of success.

All eyes will be on Ameriprise Financial as it navigates through an ever-changing market landscape while continuing to deliver innovative financial solutions tailored to its clients’ evolving needs. As more investors assess the company’s long-term potential, only time will reveal how effective Ameriprise Financial will be at sustaining growth and maintaining investor confidence.
[bs_slider_forecast ticker=”AMP”]

Institutional Investors Show Confidence and Support in Ameriprise Financial’s Growth Potential

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”AMP” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]



Ameriprise Financial, Inc., a leading provider of financial products and services, has seen significant attention from large investors in recent months. Bell Investment Advisors Inc, for example, has increased its stake in Ameriprise Financial by an impressive 47.8% during the fourth quarter. This move demonstrates the confidence that this prominent financial advisory firm has in the company.

Similarly, Coston McIsaac & Partners has also boosted their stake in Ameriprise Financial by 15.1% during the first quarter, further validating the positive sentiment surrounding the company. Quadrant Capital Group LLC and Kentucky Retirement Systems have also increased their positions in Ameriprise Financial, reaffirming their belief in the company’s potential for growth.

Clearstead Advisors LLC is another notable investor that has recently increased its holdings in Ameriprise Financial by 2.9% during the third quarter. These moves made by various institutional investors reflect a high level of confidence and support for Ameriprise Financial.

It is important to note that these investments represent only a portion of institutional ownership of AMP stock, which currently stands at an impressive 82.61%. This demonstrates great trust and belief from institutional investors in the future prospects of Ameriprise Financial.

Shares of AMP stock opened at $335.08 on July 5th, reflecting a solid performance and indicating investor optimism regarding Ameriprise Financial’s potential growth opportunities. The company’s strong financial position is highlighted by its debt-to-equity ratio of 1.43, which indicates its ability to effectively manage its debt obligations.

Ameriprise Financial achieved substantial success throughout the past year, with a 52-week low of $219.99 and a 52-week high of $357.46. The company’s steady performance is further supported by its favorable quick ratio and current ratio of 0.66 each.

The market capitalization of Ameriprise Financial stands at an impressive $34.91 billion, indicating the company’s large presence in the financial services industry. With a price-to-earnings ratio of 17.02 and a low price-to-earnings-growth ratio of 0.66, Ameriprise Financial presents itself as an attractive investment option for investors seeking stable returns.

Ameriprise Financial operates through four key segments: Advice & Wealth Management, Asset Management, Retirement & Protection Solutions, and Corporate & Other. These divisions provide a range of financial products and services to both individual and institutional clients worldwide.

Furthermore, Ameriprise Financial has recently disclosed a quarterly dividend, underscoring its commitment to providing value to its shareholders. The payment was made on May 19th to stockholders who were on record as of May 8th. The dividend offered an annualized rate of $0.40 per share with a dividend yield of 0.12%. This highlights the company’s dedication to delivering consistent returns to its investors.

Analysts have closely monitored Ameriprise Financial’s performance and stance in the market. Several research firms have weighed in on AMP shares’ potential, with Royal Bank of Canada lowering their price target from $400.00 to $385.00 but maintaining their positive outlook on the company’s prospects.

Additionally, StockNews.com recently upgraded Ameriprise Financial from a “sell” rating to a “hold” rating, suggesting that there may be favorable developments within the company that could drive future growth.

Morgan Stanley also weighed in on AMP shares, reducing their price target from $360.00 to $338.00 while maintaining an “equal weight” rating for the stock.

Overall consensus among analysts indicates a general sense of cautious optimism for Ameriprise Financial’s future performance and suggests that there is potential for growth within this sector.

In conclusion, Ameriprise Financial has attracted significant attention from large institutional investors who have increased their stakes in the company. These moves highlight a high degree of confidence in Ameriprise Financial’s potential for growth and overall stability. Additionally, the company’s solid financial position and consistent dividend payouts, coupled with favorable ratings from analysts, present a compelling investment opportunity for those seeking exposure to the financial services industry.

Tags: AMP
Roberto

Roberto

Related Posts

RLI stock news
Analyst Ratings

Growing Interest in Pentair plc: Institutional Investor Acquires Stake, CEO Sells Shares

September 14, 2023
SNDR stock news
Analyst Ratings

Douglass Winthrop Advisors LLC Increases Stake in Canadian National Railway as Company Announces Quarterly Dividend Increase

September 14, 2023
FITB stock news
Analyst Ratings

Investment Firm Reduces Holdings in Mettler-Toledo International Despite Strong Q2 Earnings

September 14, 2023
Next Post
USB stock news

FB Financial Co. Receives Increased Position from Allspring Global Investments Holdings LLC

VCIT stock news

Mixed Reviews and Varying Sentiments Surround DigitalOcean Holdings, Inc.'s Potential for Growth

BMY stock news

Analyzing the Divergent Views and Market Confusion Surrounding Asana, Inc. (NYSE: ASAN) on July 5, 2023

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
ASML Stock

ASML Shares Navigate Crosscurrents of AI Demand and Geopolitical Strain

2 months ago
Biotechnology Stock Exchange

Needham Analyst Projects Positive Future for Dayforce with 82 Price Target

2 years ago
Synopsys Stock

Synopsys Shares Plunge Following Disappointing Earnings Report

2 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Biotech Firm Ocugen Sets Ambitious Three-Year Regulatory Timeline

Wall Street Heavyweights Bet Big on Robinhood’s Transformation

Fiserv Stock: A Contrarian Bet Amid Market Pessimism

Marvell Technology Sends Mixed Signals to Investors

ProSiebenSat.1 Faces Critical Juncture as Digital Ambitions Clash with Traditional Weakness

Is Carrier Global Stock a Hidden Opportunity After Steep Decline?

Trending

Viking Therapeutics Stock
Mergers & Acquisitions

Acquisition Speculation Fuels Viking Therapeutics Rally

by Felix Baarz
October 5, 2025
0

Viking Therapeutics shares surged dramatically to close the week, posting a substantial 6.60% gain to reach $29.72....

Gladstone Capital Stock

Gladstone Capital Shares Face Sustained Downward Pressure

October 5, 2025
Eli Lilly and Stock

Eli Lilly Stock: A Clash of Investment Titans

October 5, 2025
Ocugen Stock

Biotech Firm Ocugen Sets Ambitious Three-Year Regulatory Timeline

October 5, 2025
Robinhood Stock

Wall Street Heavyweights Bet Big on Robinhood’s Transformation

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Acquisition Speculation Fuels Viking Therapeutics Rally
  • Gladstone Capital Shares Face Sustained Downward Pressure
  • Eli Lilly Stock: A Clash of Investment Titans

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com